MedTrace Logo

Plan A Novel Delivery Device Study

NCT06891729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-11-28

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety and usability of the Delivery Lumen Access Device (DLAD) in accessing the vas deferens in up to 30 healthy males. This is a prospective, non-randomized, open label interventional study.

Conditions

  • Healthy Male Adults Participants
  • Vasectomy

Interventions

DEVICE

Delivery Lumen Access Device

Delivery Lumen Access Device use prior to Vasectomy

DEVICE

DLAD

Participants will be exposed to the DLAD during their planned vasectomy

Sponsors & Collaborators

  • Southern Star Research

    collaborator INDUSTRY

  • Next Life Sciences

    lead INDUSTRY

Principal Investigators

  • Darlene Walley · Next Life Sciences

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-15
Primary Completion
2025-06-29
Completion
2025-06-30
FDA Device
Yes

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06891729 on ClinicalTrials.gov